NEWLIMIT, INC.

Profile

Company Names

NEWLIMIT, INC.

Addresses

901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

415-603-9539

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$202,045,264.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-05-02 
$129,799,764.00 
$129,999,762.00 
$199,998.00 
Equity 
1
2023-05-08 
$72,245,500.00 
$72,245,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
ARMSTRONG 
DIRECTOR
RB CAPITAL, INC.   |  COINBASE INC.   |  ROUNDPEGG, INC.   |  DIZZION, INC.   |  COINBASE GLOBAL, INC.   |  POST.BID.SHIP., INC.   |  NEWLIMIT, INC.   |  RESEARCHHUB TECHNOLOGIES, INC.
BLAKE 
 
BYERS 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  IONQ, INC.   |  SPOTLIGHT THERAPEUTICS, INC.   |  NEUTRON HOLDINGS, INC.   |  NEWLIMIT, INC.
ZAVAIN 
 
DAR 
DIRECTOR
RECURSION PHARMACEUTICALS, INC.   |  TEMPO AUTOMATION, INC.   |  DIMENSION CAPITAL I, L.P.   |  ENVEDA THERAPEUTICS, INC.   |  NEWLIMIT, INC.
JACOB 
 
KIMMEL 
DIRECTOR, EXECUTIVE OFFICER
NEWLIMIT, INC.
MICHAEL 
 
POLANSKY 
EXECUTIVE OFFICER
TOPGUEST, INC.   |  AIRTIME MEDIA, INC.   |  PHILOTIC INC   |  ELASTIC PROJECTS, INC.   |  OUTER BIOSCIENCES, LLC   |  NEWLIMIT, INC.   |  RESEARCHHUB TECHNOLOGIES, INC.   |  HAWKTAIL II, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-02 
2025-01-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-08 
2023-05-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#